Global Market Direct’s pharmaceuticals report, “Pevion Biotech Ltd - Product Pipeline Review - H2 2011” provides data on the Pevion Biotech Ltd’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Pevion Biotech Ltd’s corporate website, SEC filings, investor presentations and featured press releases, both from Pevion Biotech Ltd and industry-specific third party sources, put together by Global Markets Direct’s team.
Pevion Biotech Ltd - Brief Pevion Biotech Ltd overview including business description, key information and facts, and its locations and subsidiaries.
Review of current pipeline of Pevion Biotech Ltd human therapeutic division.
Overview of pipeline therapeutics across various therapy areas.
Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
Product profiles for late stage and clinical stage products of Pevion Biotech Ltd with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
Recent updates of the Pevion Biotech Ltd’s pipeline in the last quarter.
Key discontinued and dormant projects.
Latest news and deals relating to the products.
Reasons to buy
Evaluate Pevion Biotech Ltd’s strategic position with total access to detailed information on its product pipeline.
Assess the growth potential of Pevion Biotech Ltd in its therapy areas of focus.
Identify new drug targets and therapeutic classes in the Pevion Biotech Ltd’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
Exploit collaboration and partnership opportunities with Pevion Biotech Ltd.
Avoid Intellectual Property Rights related issues.
Explore the dormant and discontinued projects of Pevion Biotech Ltd and identify potential opportunities in those areas.